BIOLASE Rating Increased to Buy at Sidoti (BIOL)
BIOLASE (NASDAQ:BIOL) was upgraded by analysts at Sidoti from a “neutral” rating to a “buy” rating in a research report issued to clients and investors on Thursday, TheFlyOnTheWall.com reports.
Shares of BIOLASE (NASDAQ:BIOL) traded up 5.50% on Thursday, hitting $2.11. The stock had a trading volume of 670,280 shares. BIOLASE has a 52-week low of $1.1554 and a 52-week high of $6.0019. The stock’s 50-day moving average is $2.37 and its 200-day moving average is $3.79. The company’s market cap is $72.0 million.
BIOLASE (NASDAQ:BIOL) last issued its quarterly earnings data on Wednesday, August 7th. The company reported ($0.06) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.04) by $0.02. The company had revenue of $14.20 million for the quarter, compared to the consensus estimate of $15.69 million. The company’s quarterly revenue was up 16.4% on a year-over-year basis. Analysts expect that BIOLASE will post $-0.21 EPS for the current fiscal year.
BIOL has been the subject of a number of other recent research reports. Analysts at Zacks downgraded shares of BIOLASE (NASDAQ:BIOL) from a “neutral” rating to an “underperform” rating in a research note to investors on Monday, September 2nd. They now have a $1.60 price target on the stock. Separately, analysts at WallachBeth Capital cut their price target on shares of BIOLASE (NASDAQ:BIOL) from $6.50 to $4.50 in a research note to investors on Thursday, August 8th. They now have a “buy” rating on the stock. Finally, analysts at Ascendiant Capital Markets reiterated a “buy” rating on shares of BIOLASE (NASDAQ:BIOL) in a research note to investors on Wednesday, July 3rd. They now have a $5.50 price target on the stock, down previously from $6.50.
One investment analyst has rated the stock with a sell rating and four have given a buy rating to the stock. BIOLASE presently has a consensus rating of “Buy” and an average price target of $4.65.
BIOLASE, Inc, formerly BIOLASE Technology, Inc is a medical technology company that develops, manufactures and markets lasers, and markets and distributes dental imaging equipment and other related products designed for applications and procedures in dentistry and medicine.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.